Interleukin-1β regulates the human brain natriuretic peptide promoter via Ca2+-dependent protein kinase pathways

Hypertension

Volumn 35, Issue 1 II, 2000, Pages 292-296

  He, Quan ^a   LaPointe, Margot C ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

Calcineurin; Calcium; Myocytes; Protein kinases

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CALCINEURIN; CALCIUM; INTERLEUKIN 1BETA; PROTEIN KINASE; CALMODULIN DEPENDENT PROTEIN KINASE II; CALMODULIN-DEPENDENT PROTEIN KINASE II; INTERLEUKIN 1; PROTEIN KINASE (CALCIUM,CALMODULIN); PROTEIN KINASE C;

ANIMAL CELL; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVITY; HEART MUSCLE CELL; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; ANIMAL; ARTICLE; CALCIUM SIGNALING; CARDIOMEGALY; CELL CULTURE; CYTOLOGY; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HEART MUSCLE; HEART VENTRICLE; HUMAN; METABOLISM; PHYSIOLOGY; PROMOTER REGION; SPRAGUE DAWLEY RAT;

ANIMALS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CALCINEURIN; CALCIUM; CALCIUM SIGNALING; CARDIOMEGALY; CELLS, CULTURED; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEART VENTRICLES; HUMANS; INTERLEUKIN-1; MAP KINASE SIGNALING SYSTEM; MYOCARDIUM; NATRIURETIC PEPTIDE, BRAIN; PROMOTER REGIONS (GENETICS); PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY; TRANSFECTION;

EID: 0033631288     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.35.1.292     Document Type: Conference Paper

References (43)

1. Dinarello CA. Interleukin-1 and interleukin-1 antagonism. Blood. 1991; 77:1627-1652.
2. Testa M, Yeh M, Lee P, Faneli R, Loperfido F, Berman JW, Lejemtel TH. Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension. J Am Coll Cardiol. 1996;28:964-971.
3. Yue P, Massie BM, Simpson PC, Long CS. Cytokine expression increases in nonmyocytes from rats with postinfarction heart failure. Am J Physiol. 1998;275:H250-H258.
4. Kyriakis JM, Avruch J. Protein kinase cascades activated by stress and inflammatory cytokines. BioEssay. 1996;18:567-577.
5. Kacimi R, Long CS, Karliner JS. Chronic hypoxia modulates the interleukin-1β-stimulated inducible nitric oxide synthase pathway in cardiac myocytes. Circulation. 1997;96:1937-1943.
6. 2 biosynthesis stimulated by interleukin-1β. J Biol Chem. 1997;272:8083-8089.
7. Harding P, Carretero OA, LaPointe MC. Effects of interleukin-1β and nitric oxide on cardiac myocytes. Hypertension. 1995;25:421-430.
8. Ridley SH, Sarsfield SJ, Lee JC, Bigg HF, Cawston TE, Taylor DJ, DeWitt DL, Saklatvala J. Actions of IL-1 are selectively controlled by p38 mitogen-activated protein kinase. J Immunol. 1997;158:3165-3173.
9. 2 metabolites regulate inducible nitric oxide synthase in cardiac myocytes. Hypertension. 1998; 31:218-224.
10. Kacimi R, Karliner JS, Koudssi F, Long CS. Expression and regulation of adhesion molecules in cardiac cells by cytokines. Circ Res. 1998;82: 576-586.
11. Thaik CM, Calderone A, Takahashi N, Colucci WS. Interleukin-1β modulates the growth and phenotype of neonatal rat cardiac myocytes. J Clin Invest. 1995;96:1093-1099.
12. He Q, LaPointe MC. Interleukin-1β regulation of the human brain natriuretic peptide promoter involves Ras-, Rac-, and p38 kinase-dependent pathways in cardiac myocytes. Hypertension. 1999;33:283-289.
13. 2 terminal kinase and p38 by IL-1 and TNF in human articular chondrocytes. J Clin Invest. 1996;98: 2425-2430.
14. Scherel PA, Pratta MA, Feeser WS, Tancula EJ, Arner EC. The effect of IL-1 on mitogen-activated protein kinases in rabbit articular chondrocytes. Biochem Biophys Res Commun. 1997;230:573-577.
15. Luo L, Cruz T, McCulloch C. Interleukin 1-induced calcium signalling in chondrocytes requires focal adhesions. Biochem J. 1997;324:653-658.
16. Wilkinson MF, Earle ML, Triggle CR, Barnes S. Interleukin-1β, tumor necrosis factor-α, and LPS enhance calcium channel current in isolated vascular smooth muscle cells of rat tail artery. FASEB J. 1996;10: 785-791.
17. 2+ transients and adenylate cyclase activity. Am J Physiol. 1997;272: H1937-H1944.
18. Zhang XQ, Moore RL, Tillotson DL, Cheung JY. Calcium currents in postinfarction rat cardiac myocytes. Am J Physiol. 1995;269: C1464-C1473.
19. Ganz MB, Saksa B, Saxena R, Hawkins K, Sedor JR. PDGF and IL-1 induce and activate specific protein kinase C isoforms in mesangial cells. Am J Physiol. 1996;271:F108-F113.
20. Simpson PC. β-Protein kinase C and hypertrophic signaling in human heart failure. Circulation. 1999;99:334-337.
21. 2+-sensitive isoforms in the failing human heart. Circulation. 1999;99:384-391.
22. 2+/calmodulin-dependent protein kinase II regulates atrial natriuretic factor gene expression in ventricular myocytes. J Biol Chern. 1997;272: 31202-31208.
23. Bassani RA, Mattiazzi A, Bers DM. CaMKII is responsible for activity-dependent acceleration of relaxation in rat ventricular myocytes. Am J Physiol. 1995;268:H703-H712.
24. Meguro T, Hong C, Asai K, Tagagi G, McKinsey TA, Olson EN, Vatner SF. Cyclosporine attenuates pressure-overload hypertrophy in mice while enhancing susceptibility to decompensation and heart failure. Circ Res. 1999;84:735-740.
25. Sugden PH. Signaling in myocardial hypertrophy: life after calcineurin? Circ Res. 1999;84:633-646.
26. Sussman MA, Lim HW, Gude N, Taigen T, Olson EN, Robbins J, Colbert MC, Gualberto A, Wieczorek DF, Molkentin JD. Prevention of cardiac hypertrophy in mice by calcineurin inhibition. Science. 1998;281: 1690-1693.
27. Molkentin JD, Lu JR, Antos CL, Markham B, Richardson J, Robbins J, Grant S, Olson EN. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell. 1998;93:215-228.
28. Ogawa Y, Nakao K. Brain natriuretic peptide as a cardiac hormone in cardiovascular disorders. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis and Management, 2nd ed. New York, NY: Raven Press; 1995:833-840.
29. Omland T, Aakvaag A, Bonarjee VVS, Caidahl K, Lie RT, Nilsen DWT, Sundsfjord JA, Dickstein K. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction: comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. Circulation. 1996; 93:1963-1966.
30. Arakawa N, Nakamura M, Aoki H, Hiramori K. Plasma brain natriuretic peptide concentrations predict survival after acute myocardial infarction. J Am Coll Cardiol. 1996;27:1656-1661.
31. Maeda K, Tsutamoto T, Wada A, Hisanaga T, Kinoshita M. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J. 1998;135:825-832.
32. Richards AM, Nicholls MG, Yandle TG, Ikram H, Espiner EA, Turner JG, Buttimore RC, Lainchbury JG, Elliot JM, Frampton C, Crozier IG, Smyth DW. Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction. Heart. 1999;81:114-120.
33. LaPointe MC, Sitkins JR. Phorbol ester stimulates the synthesis and secretion of brain natriuretic peptide from neonatal rat ventricular cardiocytes: a comparison with the regulation of atrial natriuretic factor. Mol Endocrinol. 1993;7:1284-1296.
34. LaPointe MC, Wu G, Garami M, Yang XP, Gardner DG. Tissue-specific expression of the human brain natriuretic peptide gene in cardiac myocytes. Hypertension. 1996;27:715-722.
35. 2+-ATPase. Proc Natl Acad Sci U S A. 1990;87:2466-2470.
36. 2+-calmodulin. Trends Cardiovasc Med. 1992;2:226-231.
37. 2+/calmodulin-dependent protein kinase in failing and nonfailing human myocardium. Circ Res. 1999;84:713-721.
38. 2+/calmodulin-dependent protein kinases within the nucleus. Cell Calcium. 1998;23:103-114.
39. Bhogal MS, Colyer J. Depletion of sarcoplasmic reticulum calcium prompts phosphorylation of phospholamban to stimulate store refilling. Ann NY Acad Sci. 1998;853:260-263.
40. Kanashiro CA, Khalil RA. Signal transduction by protein kinase C in mammalian cells. Clin Exp Pharmacol Physiol. 1998;25:974-985.
41. Ding B, Price RL, Borg TK, Weinberg EO, Halloran PF, Lorell BH. Pressure overload induces severe hypertrophy in mice treated with cyclosporine, an inhibitor of calcineurin. Circ Res. 1999;84:729-734.
42. Zhang W, Kowal RC, Rusnak F, Sikkink RA, Olson EN, Victor RG. Failure of calcineurin inhibitors to prevent pressure-overload left ventricular hypertrophy in rats. Circ Res. 1999;84:722-728.
43. Palmer JN, Hartogensis WE, Patten M, Fortuin FD, Long CS. Interleukin-1β induces cardiac myocyte growth but inhibits cardiac fibroblast proliferation in culture. J Clin Invest. 1995;95:2555-2564.